LOCK-IN
Live / Applied — New application — not yet assigned to an examiner (as of 20 May 2026)
What this means for you
Not registered yet, but its 20 May 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99835491
- Mark type
- Stylized text
- Filed
- 20 May 2026
- Attorney of record
- Benjamen E. Kern
Goods and services
- Class 001 — Chemicals: Biochemicals, namely, monoclonal, bispecific, and trimeric or other multispecific antibody formats, and derivatives thereof for in-vivo or in-vitro scientific research and development to treat diseases and for use in laboratories, diagnostics and analytics for scientific or research use.
- Class 005 — Pharmaceuticals: Pharmaceutical preparations based on human or animal monoclonal, bispecific, trimeric or other multispecific antibody formats, and derivatives thereof for treating diseases, for use in related diagnostic or therapeutic use, and for use as medical diagnostic assays for testing of body fluids or tissues, for use in disease detection, including, cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases.
- Class 042 — Scientific and technological services: Medical and scientific research in the fields of human or animal monoclonal, bispecific, trimeric or other multispecific antibody formats to treat diseases; medical research services, namely, protein engineering in the fields of human monoclonal, bispecific, trimeric or other multispecific antibody formats to treat diseases; pharmaceutical product development in the fields of human monoclonal or trimeric antibodies to treat diseases; contract research services in the fields of human monoclonal, bispecific, trimeric or other multispecific antibody formats to treat diseases; consulting services in the field of biotechnology and genetic science; consulting services in the field of pharmaceutical research and development; scientific research consulting in the field of biotechnology and bioengineering; providing information on the subject of scientific research in the field of biochemistry and biotechnology; research and development of new products for others.
Owner
- DNA TWOPOINTO INC., Newark, CA, US
Prosecution history
- 17 Sept 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Sept 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 20 May 2026 — APPLICATION FILING RECEIPT MAILED
- 20 May 2026 — NEW APPLICATION ENTERED